Skip to content

Comparative efficacy of repetitive peripheral magnetic stimulation and high intensity laser therapy in upper trapezius myofascial pain syndrome: A randomized controlled trial, single blind

Comparative efficacy of repetitive peripheral magnetic stimulation and high intensity laser therapy in upper trapezius myofascial pain syndrome: A randomized controlled trial, single blind

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260420004
Enrollment
24
Registered
2026-04-20
Start date
2026-05-04
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial pain syndrome is one of the most musculoskeletal pain conditions, characterized by the presence of a myofascial trigger point, which produces localized and referred pain to particular area upon irritation, most common active trigger point found in upper trapezius muscle Myofascial pain syndrome, Upper trapezius, Repetitive magnetic stimulation, High intensity laser therapy, Pain reduction, Randomized Controlled Trial, Rehabilitation, Physical Therapy modalities, Non invasive treatm

Interventions

round coil, total 3500 pulses, 10 minutes, twice a week for 3 weeks and exercise for upper trapezius myofascial pain syndrome which include stretching upper trapezius muscle and isometric strengthenin
power 3 watts, total energy 900 J, 10 minutes, twice a week for 3 weeks and exercise for upper trapezius myofascial pain syndrome which include stretching upper trapezius muscle and isometric strength
Experimental Device,Active Comparator Device
rPMS + exercise ,HILT + exercise

Sponsors

Ramathibodi hosital, Mahidol university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients with chronic neck pain and diagnosed with myofascial pain syndrome by Travell and Simons criteria, 2. Patients with taut band in upper trapezius and at least one active trigger point, 3. Persistent pain more than 3 months, 4. Patients with VAS greater than or equals to 4, 5. Patients aged 18-60 years

Exclusion criteria

Exclusion criteria: 1. Patients suspected of fibromyalgia syndrome, cervical myelopathy or radiculopathy, disc herniation, spinal stenosis, history of trauma, or pathologic findings on cervical x-ray, 2. Patients with a history of spine surgery, 3. Patients with cancer or tumors in the neck region, 4. Patients who received any myofascial pain syndrome treatment within 6 months, 5. Patients who received any treatment with repetitive magnetic stimulation or high intensity laser therapy, 6. Patients with contraindication for magnetic stimulation: cardiac pacemaker, metallic implants near the stimulation side, 7. Patients with pregnancy

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) Baseline, immediately after second, fourth, sixth session, 1 week, and 1 month post session The scale consists of a single line of 10-centimeter line that represents the continuum of pain experience. The left end of the line represents no pain, and the right end represents the worst pain.

Secondary

MeasureTime frame
Pressure pain threshold (PPT) Baseline, immediately after second, fourth, sixth session, 1 week, and 1 month post session A pressure algometer was placed directly over the active myofascial trigger point. Pressure was applied and ceased immediately when the patient reported pain. The result recorded in kg/cm2,Neck disability index Thai version (NDI-TH) Baseline, immediately after second, fourth, sixth session, 1 week, and 1 month post session Neck disability index is a specific task functional status questionnaire with 10 items to assess disability due to neck pain.

Countries

Thailand

Contacts

Public ContactNatthikul Thanteeraphap

Faculty of Medicine Ramathibodi hospital, Mahidol university

natthikulth@gmail.com0917746064

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026